Probabilistic sensitivity analysis: Be a bayesian

Value in Health

Volumn 12, Issue 8, 2009, Pages 1210-1214

  Boshuizen, Hendriek C ^a   Van Baal, Pieter H M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bayesian methods; Maximum likelihood estimation; Prior probability distribution; Probabilistic sensitivity analysis

Indexed keywords

ARTICLE; BAYES THEOREM; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR; STATISTICAL MODEL;

EID: 70350757659     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00590.x     Document Type: Article

References (20)

1. Buxton MJ, Drummond MJ, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997 6 : 217 227.
2. Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008 26 : 781 798.
3. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005 14 : 339 347.
4. Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002 360 : 711 715.
5. Oakley JE., O'Hagan A. Probabilistic sensitivity analysis of complex models: a Bayesian approach. J R Stat Soc Series B 2004 66 : 751 769.
6. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999 18 : 341 364.
7. O'Hagan A, McCabe C, Akehurst R, et al. Incorporation of uncertainty in health economic modelling studies. Pharmacoeconomics 2005 23 : 529 536. (Pubitemid 40994122)
8. Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res 2001 10 : 277 303.
9. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford : Oxford University Press, 2006.
10. Sculpher M. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008 26 : 799 806.
11. Greenland S. Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment. Risk Anal 2001 21 : 579 583.
12. Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006 15 : 373 381.
13. Ades AE, Lu G. Correlations between parameters in risk models: estimation and propagation of uncertainty by Markov Chain Monte Carlo. Risk Anal 2003 23 : 1165 1172.
14. Briggs AH, Ades AE, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Making 2003 23 : 341 350.
15. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Carre Evaluation. Chichester : John Wiley & Sons, 2004.
16. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. London : Chapman & Hall/CRC Press, 2004.
17. Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008 122 : 155 164.
18. Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008 26 : 781 798.
19. Chick SE. Input distribution selection for simulation expertiments: accounting for input uncertainty. Operations Res 2001 49 : 744 758.
20. Walker WE, Harremoes P, Rotmans J, et al. Defining uncertainty: a conceptual basis for uncertainty management in model-based decision support. Integr Assess 2003 4 : 5 17.